Known targets — ChEMBL curated mechanism
APH1AAPH1BNCSTNPSEN1PSEN2PSENEN
The experimentally established mechanism targets of Tarenflurbil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSEN1 known ✓ | P49768 | 1/20 | 1.00 |
| ▸ | PSEN2 known ✓ | P49810 | 1/20 | 1.00 |
| ▸ | APH1B known ✓ | Q8WW43 | 1/20 | 1.00 |
| ▸ | NCSTN known ✓ | Q92542 | 1/20 | 1.00 |
| ▸ | APH1A known ✓ | Q96BI3 | 1/20 | 1.00 |
| ▸ | PSENEN known ✓ | Q9NZ42 | 1/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 11/20 | 1.00 |
| ▸ | AKR1C2 | P52895 | 11/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | FABP2 | P12104 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | AKR1C4 | P17516 | 1/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 1/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Esflurbiprofen SCHEMBL505817 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL1070292 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Tarenflurbil SCHEMBL29350102 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL8754830 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL8754978 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL10029029 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL2248 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL8755275 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL3519037 | 0.98 | AKR1C3 (0.97) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 | |
| Flurbiprofen SCHEMBL9877586 | 0.98 | AKR1C3 (0.97) | AKR1C3AKR1C2PTGS1PTGS2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5658 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070903-A | Liquid slow-release preparation | 上海建毅腾创生物医药科技有限公司 | 2026-05-22 | — | — | CN | claimed |
| CN-122005686-A | External application medicine for subacute thyroiditis acute stage and preparation method thereof | 广东省中医院海南医院 | 2026-05-12 | — | — | CN | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260043007-A1 | METHOD FOR PRODUCING CARDIAC MUSCLES | KYOTO UNIVERSITY (JP) | 2026-02-12 | — | — | US | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| US-12502366-B2 | Pharmaceutical composition with low-content flurbiprofen axetil (FPA), and use thereof | WISDOM PHARMACEUTICAL CO., LTD (CN) | 2025-12-23 | — | — | US | claimed |
| EP-3350313-B1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR (SG) | 2025-11-26 | — | — | EP | claimed |
| EP-4612298-A1 | BCMA VH-ONLY CARS | Dana-Farber Cancer Institute, Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| EP-4567105-A1 | METHOD FOR PRODUCING CARDIAC MUSCLES | Kyoto University (JP) | 2025-06-11 | — | — | EP | claimed |
| EP-0212746-B1 | DRUG PARTICLES HAVING CONSTANT RELEASE | THE PROCTER & GAMBLE COMPANY (US) | 1991-04-10 | — | — | EP | claimed |
| EP-0223369-B1 | PHARMACEUTICAL COMPOSITION CONTAINING 2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID OR A SALT THEREOF | The Boots Company PLC (GB) | 1990-12-27 | — | — | EP | claimed |
| EP-0205215-B1 | PROCESS FOR THE PREPARATION OF 2-ARYLPROPIONIC ACIDS | GIST-BROCADES N.V. (NL) | 1990-08-08 | — | — | EP | claimed |
| EP-0137668-B1 | IBUPROFEN, FLURBIPROFEN AND THEIR THERAPEUTIC USE | THE UPJOHN COMPANY (US) | 1990-01-17 | — | — | EP | claimed |
| EP-0114886-B1 | IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CAFFEINE | SUNSHINE, Abraham (US) | 1987-09-30 | — | — | EP | claimed |
| EP-0109036-B1 | ANTI-INFLAMMATORY/ANALGESIC COMBINATION OF ALPHA-FLUOROMETHYLHISTIDINE AND A SELECTED NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) | MERCK & CO. INC. (US) | 1987-09-02 | — | — | EP | claimed |
| EP-0072462-B1 | PHARMACEUTICAL PREPARATIONS | Toko Yakuhin Industry Co., Ltd. (JP) | 1986-10-29 | — | — | EP | claimed |
| EP-0068838-B1 | ANALGESIC PROCESS AND COMPOSITION | THE UPJOHN COMPANY (US) | 1986-09-17 | — | — | EP | claimed |
| EP-0070714-B1 | USE OF IBUPROFEN OR FLURBIPROFEN FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING RESPIRATORY DISORDERS | THE UPJOHN COMPANY (US) | 1986-05-07 | — | — | EP | claimed |
| EP-0039051-B1 | MANNICH-BASE HYDROXAMIC ACID PRODRUGS FOR THE IMPROVED BIOAVAILABILITY OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, A PROCESS FOR PREPARING AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | MERCK & CO. INC. (US) | 1985-07-24 | — | — | EP | claimed |